Biologics

May 19, 2015
By Pharmaceutical Technology Editors
Alexion will construct a biologics facility in Ireland that is its first outside the US.
May 13, 2015
By Pharmaceutical Technology Editors
With acquisition of Oncaspar portfolio for leukemia from Sigma-Tau Finanziaria, Baxter BioScience adds an oncology infrastructure and biologic.
May 12, 2015
By Pharmaceutical Technology Editors
The agency publishes draft guidance answering industry questions about the Biologics Price Competition and Innovation Act.
May 02, 2015
Pharmaceutical Technology
The European Pharmacopoeia defines the format and content of monographs for biologicals to keep pace with recent approaches and meet the needs of its users.
May 02, 2015
Pharmaceutical Technology
While the United States and Europe still dominate, CMOs and CROs based in emerging markets continue to capture market share.
Apr 24, 2015
Pharmaceutical Technology
By Pharmaceutical Technology Editors
The agency has recommended granting marketing authorization for Opdivo.
Apr 17, 2015
Pharmaceutical Technology
By Pharmaceutical Technology Editors
The acquisition expands Sartorius Stedim Biotech’s service portfolio.
Apr 02, 2015
Pharmaceutical Technology
Multivariate data analysis (MVDA) is being used to effectively handle complex datasets generated by process analytical technology (PAT) in biopharmaceutical process development and manufacturing.
Apr 02, 2015
Pharmaceutical Technology
FDA approves a biosimilar and loses a commissioner in March.
Apr 02, 2015
Pharmaceutical Technology
In this article, industry experts discuss critical analyses for demonstrating biosimilarity.